Company
Allotera Therapeutics
A new era of Allogeneic T-Cell Therapies
Also known as Allotera Therapeutics Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Allotera Therapeutics Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Allotera is a pivotal-stage biotechnology company advancing next generation off-the-shelf therapies.
Funding snapshot
- Total raised
- $35MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series C, $35M
Funding rounds
- Series C
- $35MCompany stated
Loading relationship preview